Qiagen N.V.

NYSE:QGEN

Medical - Diagnostics & Research

Healthcare
$49.56 -0.96%

-$0.35 today

Market cap
$10.23B
Beta
0.66
P/E (TTM)
18.6
EPS (TTM)
$1.94
Dividend yield
0.69%
52W Low $32.53High $57.82

Volume 4.26M

Average 2.07M

QGEN Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Qiagen N.V.NYSE: QGEN

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) declines year over year

Q2 FY2026 weighted avg shares (diluted) of 207.83M shares fell 4.7% year over year, in line with the -4.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.5% from the prior quarter. Over 3 fiscal years it compounded at -2.3% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -4.7% toward the trailing-twelve-month pace of -4.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
207.83M-0.5% QoQ
Last fiscal yearDec 2025
207.94M-4.8% YoY
LTMJun 2026
210.75M-4.3% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.7%——
1 year-4.8%——
3-year CAGR-2.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
207.94M USD
Year-over-year change
-4.8%
4-year CAGR
-2.0%

Weighted Avg Shares (Diluted) vs competitors

How QGEN compares with its peers on the latest reported figures

  • QGEN's LTM Jun 2026 weighted avg shares (diluted) of 210.75M shares is the 4th highest of the 11 companies compared; the peer median is 149.17M shares.
  • Its year-over-year change of -4.3% is the 10th highest of 11, against a peer median of -0.8%.
  • Over three fiscal years its annual growth of -2.3% compares with a peer median of -1.1%.
QGEN Competitors Peer median
Weighted Avg Shares (Diluted) for QGEN and competitors
Company Period LTM YoY 3-year CAGR
DHRDanaher CorporationLTM Sep 2026709.15M -1.9%-1.2%
TMOThermo Fisher Scientific Inc.LTM Sep 2026373M -1.7%-1.5%
AAgilent Technologies, Inc.LTM Jul 2026283.75M -1.1%-1.8%
QGENQiagen N.V.LTM Jun 2026210.75M -4.3%-2.3%
TECHBio-Techne CorporationLTM Sep 2026157.22M -0.4%-1.0%
BRKRBruker CorporationLTM Jun 2026152.3M +0.3%+0.5%
MRVIMaravai LifeSciences Holdings, Inc.LTM Jun 2026146.04M +2.7%+3.3%
TXG10x Genomics, Inc.LTM Sep 2026129.04M +4.4%+3.1%
RVTYRevvity, Inc.LTM Jul 2026113.64M -5.8%-3.6%
RGENRepligen CorporationLTM Jun 202656.59M +0.1%-0.5%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.93M -3.1%-2.9%
Peer median (excluding QGEN) 149.17M-0.8%-1.1%

Competitors are the stored peer set for QGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.25B2.14B1.97B1.98B2.09B
Cost of Revenue800.84M756.96M731.62M1.01B798.5M
Gross Profit1.45B1.38B1.23B967.35M1.29B
Gross Margin64.4%64.7%62.8%48.9%61.8%
Research & Development189.96M189.86M198.51M193.49M187.52M
Selling, General & Admin584.47M603.95M579.17M564.36M583.67M
Operating Expenses820.74M853.1M823.75M869.64M771.19M
Depreciation & Amortization214.93M208.4M205.34M203.27M193.75M
EBITDA895.24M779.36M688.56M368.26M717.27M
EBITDA Margin39.8%36.4%35.0%18.6%34.3%
Operating Income630.08M531.46M409.94M97.71M520.31M
Operating Margin28.0%24.8%20.9%4.9%24.9%
Interest Income9.56M32.76M78.99M68.02M64.32M
Interest Expense54.48M58.36M53.41M43.84M33.26M
Other Income / Expenses(4.25M)(18.86M)19.87M23.44M(30.04M)
Income Before Tax625.83M512.6M429.81M121.15M490.27M
Pre-Tax Margin27.8%23.9%21.9%6.1%23.5%
Income Tax Expense113.23M89.39M88.51M37.56M65.39M
Net Income512.6M423.21M341.3M83.59M424.88M
Net Margin22.8%19.8%17.4%4.2%20.3%
EPS (Basic)2.522.081.670.392.04
EPS (Diluted)2.472.051.650.382.04
Weighted Avg Shares221.14M220.75M217.49M216.44M207.94M
Weighted Avg Shares (Diluted)225.07M223.23M217.49M218.48M207.94M

Qiagen N.V.

NYSE:QGEN

Intrinsic Alpha fair value

Locked

Current Price

$49.56

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.